Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder
Status:
Terminated
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether the speed of the clinical antidepressant
action of fluoxetine can be accelerated by administering DU125530 a full 5-HT1A antagonist.
Phase:
Phase 2
Details
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau